2024-26801. Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug User Fee Program
Table 1—Estimated Annual Reporting Burden 1
Prescription drug user fee activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Sections 735 and 736 of the FD&C Act (PDUFA waivers and exemptions, not including small business waiver requests) 99 1.828 181 17 3,077 Section 736(d)(1)(C) of the FD&C Act and Form FDA 3971 (small business waivers) 35 1 35 2 70 Reconsideration Requests 13 1.69 22 24 528 Appeal Requests 4 1.5 6 12 72 User Fee Cover Sheet Form FDA 3397 submission with original NDAs and BLAs 132 1.24 164 0.5 (30 minutes) 82 Total 408 3,829 1 There are no capital costs or operating and maintenance costs associated with this collection of information.
Document Information
- Published:
- 11/18/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2024-26801
- Dates:
- Either electronic or written comments on the collection of information must be submitted by January 17, 2025.
- Pages:
- 90705-90708 (4 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-4467
- PDF File:
- 2024-26801.pdf